Sartorius Stedim Biotech S.a Stock Forecast

Buy candidate since Jul 10, 2026

The Sartorius Stedim Biotech S.a. stock price gained 1.69% on the last trading day (Friday, 10th Jul 2026), rising from $20.65 to $21.00. During the last trading day the stock fluctuated 3.63% from a day low at $20.41 to a day high of $21.15. The price has fallen in 5 of the last 10 days but is still up by 4.01% over the past 2 weeks. Volume fell on the last day by -759 shares and in total, 485 shares were bought and sold for approximately $10.19 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Sartorius Stedim Biotech S.a. stock with a 90% probability to be traded between $17.66 and $23.00 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

SRTOY Signals & Forecast

The Sartorius Stedim Biotech S.a. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $20.42 and $20.12. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 22, 2026, and so far it has risen 18.64%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The stock had a Golden Star Signal on Friday, June 26, 2026 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Sartorius Stedim Biotech S.a. stock

Sartorius Stedim Biotech S.a. finds support from accumulated volume at $20.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.741 between high and low, or 3.63%. For the last week the stock has had daily average volatility of 4.32%.

Our recommended stop-loss: $20.34 (-3.12%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (SRTOY) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Sartorius Stedim Biotech S.a. to open at $20.85, and during the day (based on 14 day Average True Range), to move between $20.55 and $21.45, which gives a possible trading interval of +/-$0.90 (+/-4.37%) up or down from last closing price. If Sartorius Stedim Biotech S.a. takes out the full calculated possible swing range there will be an estimated 4.37% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $21.46 (2.17%) than the support at $20.53 (2.23%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sartorius Stedim Biotech S.a. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Sartorius Stedim Biotech S.a. stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.345 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $20.85 ( 0.697%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk